Skip to main content

$0.440 (0.00%)

High

$0.44

Low

$0.44

Trades

1

Turnover

$8,800

Volume

20,000
30 June 2023 at 3:50pm
Register to track VBS and receive email alerts.

Update on Phase I Human Trial

StockBot

416,823 posts

VBS released this announcement to the ASX on 7 September 2021, 9:37. The announcement is marked as price sensitive, and is 1 page(s) in length and 130.14kb in size.

You can view all announcements from VBS and see how they appear on a price chart on the announcements page.

At the date of this announcement, VBS was 0.002% short sold according to ASIC data. It was ranked the 584th most shorted stock on the ASX. It remains ranked 584th as of the latest reported data (10 November 2025).

Other Recent Announcements from VBS
Change in substantial holding KHPL 28 June 2023, 18:41
Notification of cessation of securities - VBS 28 June 2023, 16:15
First Two Patients Enrolled & Dosing Commenced 15 June 2023, 11:37
Update on Phase I Human Trial 7 September 2021, 9:37
Full Year Statutory Accounts 31 August 2021, 18:33
Preliminary Final Report - Appendix 4E 31 August 2021, 18:20
Progress Presentation 30 August 2021, 13:50
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track VBS and receive email alerts.